Olivia Vergnolle
Tri-Institutional Therapeutics Discovery Institute(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Viral Infections and Vectors, Microbial Natural Products and Biosynthesis, Mosquito-borne diseases and control
Most-Cited Works
- → Peptide-Based Vaccines: Current Progress and Future Challenges(2019)594 cited
- → Characterization of human glutaredoxin 2 as iron–sulfur protein: A possible role as redox sensor(2005)281 cited
- → A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition(2020)239 cited
- → Bacterial GCN5-RelatedN-Acetyltransferases: From Resistance to Regulation(2016)190 cited
- → Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients(2021)91 cited
- → Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever(2021)88 cited
- → Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis(2020)88 cited
- → Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice(2018)61 cited
- → A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants(2021)59 cited
- → Inactivation of tesA Reduces Cell Wall Lipid Production and Increases Drug Susceptibility in Mycobacteria(2011)58 cited